Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

China Biologic Products Inc (NASDAQ:CBPO)

99.63
Delayed Data
As of Mar 28
 +0.20 / +0.20%
Today’s Change
96.99
Today|||52-Week Range
137.39
-7.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.7B

Company Description

China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China.

Contact Information

China Biologic Products, Inc.
Jialong International Tower
Beijing Beijing 100125
P:861065983111
Investor Relations:
861065983099

Employees

Shareholders

Mutual fund holders46.95%
Individual stakeholders45.39%
Other institutional27.79%

Top Executives

Xiao Ying GaoChairman, President & Chief Executive Officer
Ming YangChief Financial Officer
Gang YangVice President
Bob ZhouDirector-Marketing Department
Yin MingSenior Vice President-Investor Relations